leisure time -WSS

leisure time

author：focus 2025-09-03 07:36:32 - browse：489

Susan Galbraith of AstraZeneca gestures while speaking – pharma coverage from STAT — Susan Galbraith, AstraZeneca’s head of cancer research and development, speaks at a STAT event in 2023. Marie Miller for STAT

CHICAGO — AstraZeneca’s head of cancer research and development, Susan Galbraith, is British, and prone to a particularly British style of understatement. She doesn’t boast loudly. But she did come to this year’s annual meeting of the American Society of Clinical Oncology wearing a small lapel pin with the numeral 6 and the “AZ” corporate logo.

That pin represents the number of years in a row that the London-based drug giant has had a presentation in the ASCO plenary, the conference’s biggest showcase for new data. This year, the company has two.

Scientific credibility is great, of course. But AstraZeneca’s shareholders want something else: return on investment.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： AI can’t replace a physician’s gut feeling

WSS

FDA approves RSV monoclonal antibody for infants, toddlers

Group opposing PBM reform sets lobbying record

Custom gene therapy hints at new path for rare disease treatments

STAT Virtual Event: The State of Biosimilars: What to Watch

Study: Pain burden is higher in Black NFL players than white ones

How the political right came to back psychedelics to treat trauma

hotspot

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

focus

Anesthesiologist group: stop taking Ozempic before surgery

Whistleblower: Blue Cross Blue Shield evaded $170 million in taxes

State Dept. review finds Biden bears some blame for Afghanistan failures

Key House panel plots a new health care package

In Memoriam: Notable people who died in 2023

Study: Pain burden is higher in Black NFL players than white ones

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Custom gene therapy hints at new path for rare disease treatments

Continuity nursing helped my family in our darkest PICU moments

WHO calls for emergency meeting on new China virus, as cases spread

explore

NIH fellows want a pay raise. Will that mean less money for grants?

Medicare has a new plan to address drug shortages

Insurance companies sue energy corporation after it was blamed for helping start Colorado wildfire

California’s proposed $25 per hour health care minimum wage

AI can’t replace a physician’s gut feeling

AI can’t replace a physician’s gut feeling

focus

hotspot

leisure time

knowledge